DXC Technology Co. stock underperforms Monday when compared to competitors
DXC Technology Co. closed 28.51% below its 52-week high of $24.83, which the company achieved on November 8th.
360Dx8h
Beckman Coulter Diagnostics Clinical Chemistry, Immunoassay Analyzer Nabs FDA Clearance
NEW YORK – Danaher subsidiary Beckman Coulter Diagnostics announced on Monday that its integrated clinical chemistry and immunoassay analyzer has received 510 (k) clearance from the US Food and Drug ...
Beckman Coulter announces FDA clearance of DxC 500i Clinical Analyzer
Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...
Taiwan News23h
Mainframe Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033
The average mainframe system capacity reached 60 terabytes, supporting over 3 million lines of COBOL code modernization, with hardware reliability extending system lifespans to an impressive 15 years.